Mika Yuval
Known title: See RemarksCIK: 0001949285
Associated companies
Transaction History
| OBIO | ▲ Buy | Grant | 69,333 | $0 | 5/8/2024 | View on chart |
| OBIO | ▲ Buy | Grant | 40,000 | $0 | 7/20/2023 | View on chart |
| OBIO | ▲ Buy | Option Exercise | 8,852 | — | 4/12/2023 | View on chart |
| OBIO | ▲ Buy | Grant | 40,720 | — | 1/26/2023 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
September 27, 2026
OBIO Shares Rise 5.2% Amid Positive Momentum
Orchestra BioMed Holdings (OBIO) shares recently increased by 5.2%, a move that some observers see as a sign of strengthening momentum. The stock currently trades within its 52-week range of $2.20 to $6.48. Analysts maintain an average price target of $12.14, suggesting a significant gap between the current market price and professional estimates.
OBIO Shares Rise 5.2% Amid Positive Momentum. Orchestra BioMed Holdings (OBIO) shares recently increased by 5.2%, a move that some observers see as a sign of strengthening momentum. The stock currently trades within its 52-week range of $2.20 to $6.48. Analysts maintain an average price target of $12.14, suggesting a significant gap between the current market price and professional estimates.